Oxidized low density lipoproteins-do we know enough about them?

Cardiovascular Drugs and Therapy

Volumn 25, Issue 5, 2011, Pages 367-377

  Jiang, Xueting ^a   Yang, Zhaohui ^a   Chandrakala, Aluganti Narasimhulu ^a   Pressley, Dawn ^a   Parthasarathy, Sampath ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Aldehydes; Antioxidants; Atherosclerosis; Lipid peroxidation; Lipid peroxides; Scavenger receptors

Indexed keywords

ALDEHYDE DERIVATIVE; ALPHA TOCOPHEROL; ANTIOXIDANT; CELL SURFACE RECEPTOR; CHOLESTEROL ESTER; COPPER; DISTEAROYLPHOSPHATIDYLCHOLINE; OXIDIZED LOW DENSITY LIPOPROTEIN; POLYUNSATURATED FATTY ACID;

ARTICLE; ATHEROSCLEROSIS; CELL TYPE; ENDOTHELIUM CELL; HUMAN; LIPID COMPOSITION; LIPID PEROXIDATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; ANTIOXIDANTS; ATHEROSCLEROSIS; CLINICAL TRIALS AS TOPIC; FATTY ACIDS, UNSATURATED; HUMANS; LIPOPROTEINS, LDL; OXIDATION-REDUCTION;

EID: 83055181392     PISSN: 09203206     EISSN: 15737241     Source Type: Journal    
DOI: 10.1007/s10557-011-6326-4     Document Type: Article

References (83)

1. D Steinberg JL Witztum 1990 Lipoproteins and atherogenesis; current concepts J Am Med Assoc 264 3047 3052 10.1001/jama.264.23.3047 1:CAS:528:DyaK3MXltFWmurs%3D
2. R Ross 1993 The pathogenesis of atherosclerosis; a perspective for the 1990s Nature 362 801 809 8479518 10.1038/362801a0 1:CAS:528:DyaK3sXktVGqu7c%3D (Pubitemid 23132154)
3. JL Goldstein YK Ho SK Basu MS Brown 1979 Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition Proc Natl Acad Sci U S A 76 333 337 218198 10.1073/pnas.76.1.333 1:CAS:528:DyaE1MXhtFylu7g%3D (Pubitemid 9110191)
4. MS Brown SK Basu JR Falck YK Ho JL Goldstein 1980 The scavenger cell pathway for lipoprotein degradation: specificity of the binding site that mediates the uptake of negatively-charged LDL by macrophages J Supramol Struct 13 67 81 6255257 10.1002/jss.400130107 1:CAS:528:DyaL3MXisl2ltw%3D%3D (Pubitemid 11160139)
5. AM Fogelman I Shechter J Seager M Hokom JS Child PA Edwards 1980 Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages Proc Natl Acad Sci U S A 77 2214 2218 6769124 10.1073/pnas.77.4.2214 1:CAS:528:DyaL3cXkt1eqsrY%3D (Pubitemid 10089629)
6. UP Steinbrecher JL Witztum S Parthasarathy D Steinberg 1987 Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL. Correlation with changes in receptor mediated catabolism Arteriosclerosis 7 135 143 3107534 10.1161/01.ATV.7.2.135 1:CAS:528:DyaL2sXltlWnur8%3D (Pubitemid 17061134)
7. T Henriksen EM Mahoney D Steinberg 1981 Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins Proc Natl Acad Sci U S A 78 6499 6503 6273873 10.1073/pnas.78.10.6499 1:CAS:528: DyaL3MXmtFymt7g%3D (Pubitemid 12179740)
8. T Henriksen EM Mahoney D Steinberg 1982 Interactions of plasma lipoproteins with endothelial cells Ann N Y Acad Sci 401 102 116 6301324 10.1111/j.1749-6632.1982.tb25711.x 1:CAS:528:DyaL3sXhsFyltL4%3D
9. T Henriksen EM Mahoney D Steinberg 1983 Enhanced macrophage degradation of biologically modified low density lipoprotein Arteriosclerosis 3 149 159 6838433 10.1161/01.ATV.3.2.149 1:STN:280:DyaL3s7nslKqtA%3D%3D (Pubitemid 13136501)
10. A Harris S Devaraj I Jialal 2002 Oxidative stress, alpha-tocopherol therapy, and atherosclerosis Curr Atherosclerosis Rep 4 373 380 10.1007/s11883-002-0075-6
11. P Delerive C Furman E Teissier J Fruchart P Duriez B Staels 2000 Oxidized phospholipids activate PPARalpha in a phospholipase A2-dependent manner FEBS Lett 471 34 38 10760508 10.1016/S0014-5793(00)01364-8 1:CAS:528: DC%2BD3cXit1Wgur0%3D (Pubitemid 30173288)
12. S Parthasarathy J Barnett 1990 Phospholipase A2 activity of low density lipoprotein: evidence for an intrinsic phospholipase A2 activity of apoprotein B-100 Proc Natl Acad Sci U S A 87 9741 9745 2263624 10.1073/pnas.87.24.9741 1:CAS:528:DyaK3MXpslWlsw%3D%3D (Pubitemid 120016519)
13. W Siess KJ Zangl M Essler M Bauer R Brandl C Corrinth R Bittman G Tigyi M Aepfelbacher 1999 Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions PNAS 96 6931 6936 10359816 10.1073/pnas.96.12.6931 1:CAS:528:DyaK1MXks1Wkt70%3D (Pubitemid 29274987)
14. W Palinski ME Rosenfeld S Yla-Herttuala GC Gurtner SS Socher SW Butler S Parthasarathy TE Carew D Steinberg JL Witztum 1989 Low density lipoprotein undergoes oxidative modification in vivo Proc Natl Acad Sci U S A 86 1372 1376 2465552 10.1073/pnas.86.4.1372 1:CAS:528:DyaL1MXhvV2rtb4%3D (Pubitemid 19061548)
15. JR Requena MX Fu MU Ahmed AJ Jenkins TJ Lyons JW Baynes SR Thorpe 1997 Quantification of malondialdehyde and 4-hydroxynonenal adducts to lysine residues in native and oxidized human low-density lipoprotein Biochem J 322 317 325 9078279 1:CAS:528:DyaK2sXhslKqsrs%3D
16. H Esterbauer G Striegl H Puhl M Rotheneder 1989 Continuous monitoring of in vitro oxidation of human low density lipoprotein Free Radic Res Commun 6 67 75 2722022 10.3109/10715768909073429 1:CAS:528:DyaL1MXkvFeiu7k%3D (Pubitemid 19109796)
17. S Parthasarathy 1987 Oxidation of low-density lipoprotein by thiol compounds leads to its recognition by the acetyl LDL receptor Biochim Biophys Acta 917 337 340 3801507 1:CAS:528:DyaL2sXpvVejtQ%3D%3D (Pubitemid 17004984)
18. CP Sparrow J Olszewski 1993 Cellular oxidation of low density lipoprotein is caused by thiol production in media containing transition metal ions J Lipid Res 34 219 228
19. O Quehenberger G Jurgens S Zadravec H Esterbauer 1988 Oxidation of human low density lipoprotein initiated by copper (II) chloride Basic Life Sci 49 387 390 3250498 1:CAS:528:DyaL1MXlsVygsrY%3D
20. GA Francis 2000 High density lipoprotein oxidation: in vitro susceptibility and potential in vivo consequences Biochim Biophys Acta 1483 217 235 10634938 1:CAS:528:DC%2BD3cXjt1eqsQ%3D%3D (Pubitemid 30029054)
21. T Spranger B Finckh R Fingerhut A Kohlschutter U Beisiegel A Kontush 1998 How different constituents of human plasma and low density lipoprotein determine plasma oxidizability by copper Chem Phys Lipids 91 39 52 9488998 10.1016/S0009-3084(97)00092-3 1:CAS:528:DyaK2sXotVOqt70%3D (Pubitemid 28056879)
22. F Ferguson S Parthasarathy J Joseph B Kalyanaraman 1998 Generation and initial characterization of a novel polyclonal antibody directed against homocysteine thiolactone-modified low density lipoprotein J Lipid Res 39 925 933 9555955 1:CAS:528:DyaK1cXitlygsr4%3D (Pubitemid 28163292)
23. H Arai BS Berlett PB Chock ER Stadman 2005 Effect of bicarbonate on iron-mediated oxidation of low-density lipoprotein PNAS 102 10472 10477 16027354 10.1073/pnas.0504685102 1:CAS:528:DC%2BD2MXntVSitL4%3D (Pubitemid 41061578)
24. T Sakurai S Kimura M Nakano H Kimura 1991 Oxidative modification of glycated low density lipoprotein in the presence of iron Biochem Biophys Res Commun 177 433 439 2043128 10.1016/0006-291X(91)92002-2 1:CAS:528: DyaK3MXksVOitro%3D
25. SM Lynch B Frei 1993 Mechanisms of copper- and iron-dependent oxidative modification of human low density lipoprotein J Lipid Res 34 1745 1753 8245725 1:CAS:528:DyaK3sXms1OgsL8%3D (Pubitemid 23298718)
26. S Parthasarathy J Barnett LG Fong 1990 High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein Biochim Biophys Acta 1044 275 283 1:CAS:528:DyaK3cXkt1Wlsb4%3D (Pubitemid 20151285)
27. JW Heinecke 1998 Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis Atherosclerosis 141 1 15 9863534 10.1016/S0021-9150(98)00173-7 1:CAS:528:DyaK1cXntVyjt7k%3D (Pubitemid 28539412)
28. Y Rikitake S Kawashima S Takeshita T Yamashita H Azumi M Yasuhara H Nishi N Inoue M Yokoyama 2001 Anti-oxidative properties of fluvastatin, an HMG-CoA reductase inhibitor, contribute to prevention of atherosclerosis in cholesterol-fed rabbits Atherosclerosis 154 87 96 11137086 10.1016/S0021- 9150(00)00468-8 1:CAS:528:DC%2BD3MXnslWkug%3D%3D (Pubitemid 32008567)
29. LL Stoll ML McCormick GM Denning NL Weintraub 2004 Antioxidant effects of statins Drugs Today (Barc) 40 975 990 10.1358/dot.2004.40.12.872573 1:CAS:528:DC%2BD2MXis1Smtrk%3D (Pubitemid 40128717)
30. SD Cushing JA Berliner AJ Valente MC Territo M Navab F Parhami R Gerrity CJ Schwartz AM Fogelman 1990 Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells Proc Natl Acad Sci U S A 87 5134 5138 1695010 10.1073/pnas.87.13.5134 1:CAS:528:DyaK3cXkvFGmtLg%3D (Pubitemid 20224287)
31. F Liao JA Berliner M Mehrabian M Navab LL Demer AJ Lusis AM Fogelman 1991 Minimally modified low density lipoprotein is biologically active in vivo in mice J Clin Investig 87 2253 2257 2040705 10.1172/JCI115261 1:CAS:528: DyaK3MXksVOjtbY%3D
32. S Parthasarathy LG Fong D Otero D Steinberg 1987 Recognition of solubilized apoproteins from delipidated, oxidized low density lipoprotein (LDL) by the acetyl-LDL receptor Proc Natl Acad Sci U S A 84 537 540 3467373 10.1073/pnas.84.2.537 1:CAS:528:DyaL2sXhsFektLk%3D (Pubitemid 17006230)
33. LG Fong S Parthasarathy JL Witztum D Steinberg 1987 Nonenzymatic oxidative cleavage of peptide bonds in apoprotein B-100 J Lipid Res 28 1466 1477 3323390 1:CAS:528:DyaL1cXht1Kqtr4%3D (Pubitemid 18025879)
34. Parthasarathy S. Modified lipoproteins in the pathogenesis of atherosclerosis. Austin: R.G. Landes Co; 1994. p. 152.
35. AT Lada LL Rudel 2004 Associations of low density lipoprotein particlecomposition with atherogenicity Curr Opin Lipidol 15 19 24 15166804 10.1097/00041433-200402000-00005 1:CAS:528:DC%2BD2cXjsFersrs%3D (Pubitemid 39118013)
36. Parthasarathy S, Ragahavamenon A, Garelnabi MO, Santanam, N. Oxidized low-density lipoprotein. In: Uppu RM et al., editors. Free radicals and antioxidant protocols, methods in molecular biology. 1998. p. 403-417
37. D Steinberg S Parthasarathy TE Carew JC Khoo JL Witztum 1989 Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity N Engl J Med 320 915 924 2648148 10.1056/NEJM198901053200122 1:CAS:528:DyaL1MXit12hur0%3D (Pubitemid 19101597)
38. JJ Moreno MT Mitjavila 2003 The degree of unsaturation of dietary fatty acids and the development of atherosclerosis (review) J Nutr Biochem 14 182 195 12770642 10.1016/S0955-2863(02)00294-2 1:CAS:528:DC%2BD3sXktFGlsr4%3D (Pubitemid 36593457)
39. S Picard S Parthasarathy J Fruebis JL Witztum 1992 Aminoguanidine inhibits oxidative modification of low density lipoprotein protein and the subsequent increase in uptake by macrophage scavenger receptors Proc Natl Acad Sci U S A 89 6876 6880 1495978 10.1073/pnas.89.15.6876 1:CAS:528: DyaK38XlsVehsrc%3D
40. A Giessauf B van Wickern T Simat H Steinhart H Esterbauer 1996 Formation of N-formylkynurenine suggests the involvement of apolipoprotein B-100 centered tryptophan radicals in the initiation of LDL lipid peroxidation FEBS Lett 389 136 140 8766816 10.1016/0014-5793(96)00546-7 1:CAS:528:DyaK28XjvFGht70%3D (Pubitemid 26226486)
41. UP Steinbrecher S Parthasarathy DS Leake JL Witztum D Steinberg 1984 Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids Proc Natl Acad Sci U S A 81 3883 3887 6587396 10.1073/pnas.81.12.3883 1:CAS:528: DyaL2cXksFagtLw%3D (Pubitemid 14087823)
42. J Shen E Herderick JF Cornhill E Zsigmond HS Kim H Kuhn NV Guevara L Chan 1996 Macrophagemediated 15-lipoxygenase expression protects against atherosclerosis development J Clin Investig 98 2201 2208 8941635 10.1172/JCI119029 1:CAS:528:DyaK28XntVOhs7Y%3D (Pubitemid 26394192)
43. D Harats A Shaish J George M Mulkins H Kurihara H Levkovitz E Sigal 2000 Overexpression of 15-lipoxygenase in vascular endothelium accelerates early atherosclerosis in LDL receptor-deficient mice Arterioscler Thromb Vasc Biol 20 2100 2105 10978255 10.1161/01.ATV.20.9.2100 1:CAS:528:DC%2BD3cXntV2itL4%3D
44. Y Huo L Zhao MC Hyman P Shashkin BL Harry T Burcin SB Forlow MA Stark DF Smith S Clarke S Srinivasan CC Hedrick D Pratico JL Witztum JL Nadler CD Funk K Ley 2004 Critical role of macrophage 12/15-lipoxygenase for atherosclerosis in apolipoprotein E-deficient mice Circulation 110 2024 2031 15451785 10.1161/01.CIR.0000143628.37680.F6 1:CAS:528:DC%2BD2cXnvFamsrk%3D (Pubitemid 39331917)
45. DL Tribble EL Gong C Leeuwenburgh JW Heinecke EL Carlson JG Verstuyft CJ Epstein 1997 Fatty streak formation in fat-fed mice expressing human copper-zinc superoxide dismutase Arterioscler Thromb Vasc Biol 17 1734 1740 9327771 10.1161/01.ATV.17.9.1734 1:CAS:528:DyaK2sXmslOrsrs%3D (Pubitemid 27423995)
46. R Patel U Diczfalusy S Dzeletovic M Wilson V Darley-Usmar 1996 Formation of oxysterols during oxidation of low density lipoprotein by peroxynitrite, myoglobin, and copper J Lipid Res 37 2361 2371 8978488 1:CAS:528:DyaK2sXms1Wm (Pubitemid 26427450)
47. DJ Lamb DS Leake 1994 Iron released from transferrin at acidic pH can catalyse the oxidation of low density lipoprotein FEBS Lett 352 15 18 7925932 10.1016/0014-5793(94)00903-1 1:CAS:528:DyaK2cXmvFOktb8%3D (Pubitemid 24291749)
48. DJ Lamb RC Hider DS Leake 1993 Hydroxypyridinones and desferrioxamine inhibitmacrophage mediated LDL oxidation by iron but not by copper Biochem Soc Trans 21 234S 8224391 1:CAS:528:DyaK3sXkvVGktrw%3D (Pubitemid 23265647)
49. ML Brennan MM Anderson DM Shih XD Qu X Wang AC Mehta LL Lim W Shi SL Hazen JS Jacob JR Crowley JW Heinecke AJ Lusis 2001 Increased atherosclerosis in myeloperoxidase deficient mice J Clin Investig 107 419 430 11181641 10.1172/JCI8797 1:CAS:528:DC%2BD3MXhtlWktLs%3D (Pubitemid 32167988)
50. TS McMillen JW Heinecke RC LeBoeuf 2005 Expression of human myeloperoxidase by macrophages promotes atherosclerosis in mice Circulation 111 2798 2804 15911707 10.1161/CIRCULATIONAHA.104.516278 1:CAS:528: DC%2BD2MXksVait74%3D (Pubitemid 40791552)
51. N Santanam S Parthasarathy 1995 Paradoxical actions of antioxidants in the oxidation of low density lipoprotein by peroxidases J Clin Investig 95 2594 2600 7769102 10.1172/JCI117961 1:CAS:528:DyaK2MXmtV2qs70%3D
52. S Gieseg S Duggan JM Gebicki 2000 Peroxidation of proteins before lipids in U937 cells exposed to peroxyl radicals Biochem J 350 215 218 10926846 10.1042/0264-6021:3500215 1:CAS:528:DC%2BD3cXmsVejsrg%3D
53. B Frei TM Forte BN Ames CE Cross 1991 Gas phase oxidants of cigarette smoke induce lipid peroxidation and changes in lipoprotein properties in human blood plasma. Protective effects of ascorbic acid Biochem J 277 133 138 1854329 1:CAS:528:DyaK3MXksVCjtb0%3D
54. A Bhatnagar 2004 Cardiovascular pathophysiology of environmental pollutants Am J Physiol Heart Circ Physiol 286 H479 H485 14715496 10.1152/ajpheart.00817.2003 1:CAS:528:DC%2BD2cXhsFKrtr8%3D (Pubitemid 38140326)
55. A Bouloumie T Marumo M Lafontan R Busse 1999 Leptin induces oxidative stress in human endothelial cells FASEB J 13 1231 1238 10385613 1:CAS:528:DyaK1MXktlOrurw%3D (Pubitemid 29300368)
56. SM Rankin S Parthasarathy D Steinberg 1991 Evidence for a dominant role of lipoxygenase(s) in the oxidation of LDL by mouse peritoneal macrophages J Lipid Res 32 449 456 1906087 1:CAS:528:DyaK3MXitVCrtrg%3D
57. NR Damasceno A Sevanian E Apolinario JM Oliveira I Fernandes DS Abdalla 2006 Detection of electronegative low density lipoprotein (LDL) in plasma and atherosclerotic lesions by monoclonal antibody-based immunoassays Clin Biochem 39 28 38 16310760 10.1016/j.clinbiochem.2005.09.014 1:CAS:528:DC%2BD28Xks1Kq (Pubitemid 43005267)
58. MR Barros MC Bertolami DS Abdalla WP Ferreira 2006 Identification of mildly oxidized low-density lipoprotein (electronegative LDL) and its auto-antibodies IgG in children and adolescents hypercholesterolemic off springs Atherosclerosis 184 103 107 15899483 10.1016/j.atherosclerosis.2004.11.027 1:CAS:528:DC%2BD2MXht1Olu73P (Pubitemid 41721075)
59. K Chiang S Parthasarathy N Santanam 2004 Estrogen, neutrophils and oxidation Life Sci 75 2425 2438 15350818 10.1016/j.lfs.2004.04.035 1:CAS:528:DC%2BD2cXntlemur0%3D (Pubitemid 39180047)
60. SL Hazen JW Heinecke 1997 3-chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima J Clin Investig 99 2075 2081 9151778 10.1172/JCI119379 1:CAS:528:DyaK2sXjtFCisLY%3D (Pubitemid 27203762)
61. MC Meuwese ES Stroes SL Hazen JN Van Miert JA Kuivenhoven RG Schaub NJ Wareham R Luben JJ Kastelein KT Khaw SM Boekholdt 2007 Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study J Am Coll Cardiol 50 159 165 17616301 10.1016/j.jacc.2007.03.033 1:CAS:528:DC%2BD2sXnsFymu7c%3D (Pubitemid 47002189)
62. I Parastatidis L Thomson DM Fries RE Moore J Tohyama X Fu SL Hazen HF Heijnen MK Dennehy DC Liebler DJ Rader H Ischiropoulos 2007 Increased protein nitration burden in the atherosclerotic lesions and plasma of apolipoprotein A-I deficient mice Circ Res 107 368 376 10.1161/CIRCRESAHA.107.157537 (Pubitemid 47267705)
63. AK Thukkani J McHowat FF Hsu ML Brennan SL Hazen DA Ford 2003 Identification of alpha-chloro fatty aldehydes and unsaturated lysophosphatidylcholine molecular species in human atherosclerotic lesions Circulation 108 3128 3133 14638540 10.1161/01.CIR.0000104564.01539.6A 1:CAS:528:DC%2BD3sXpvVSjt7k%3D (Pubitemid 38031803)
64. S Sugiyama Y Okada GK Sukhova R Virmani JW Heinecke P Libby 2001 Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes Am J Pathol 158 879 891 11238037 10.1016/S0002-9440(10)64036- 9 1:CAS:528:DC%2BD3MXitlOnurY%3D (Pubitemid 32221781)
65. C Bergt S Pennathur X Fu J Byun K O'Brien T McDonald P Singh GM Anantharamaiah A Chait J Brunzell RL Geary JF Oram JW Heinecke 2004 The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport Proc Natl Acad Sci U S A 101 13032 13037 15326314 10.1073/pnas.0405292101 1:CAS:528:DC%2BD2cXnslCks74%3D (Pubitemid 39167578)
66. AP Kumar FJ Piedrafita WF Reynolds 2003 Peroxisome proliferator-activated receptor gamma ligands regulate myeloperoxidase expression in macrophages by an estrogen-dependent mechanism involving the -463GA promoter polymorphism J Biochem 279 8300 8315 (Pubitemid 38294722)
67. KP Moore V Darley-Usmar J Morrow LJ Roberts 1995 Formation of F2-isoprostanes during oxidation of human low-density lipoprotein and plasma by peroxynitrite Circ Res 77 335 341 7614720 1:CAS:528:DyaK2MXntFart7Y%3D
68. K Moore LJ Roberts 1998 Measurement of lipid peroxidation Free Radic Res 28 659 671 9736317 10.3109/10715769809065821 1:CAS:528:DyaK1cXlvFegtbo%3D (Pubitemid 28454258)
69. N Santanam R Shem-Brewer R McClatchey PZ Castellano AA Murphy S Voelkel S Parthasarathy 1998 Estradiol as an antioxidant: incompatible with its physiological concentrations and function J Lipid Res 39 2111 2118 9799796 1:CAS:528:DyaK1cXnsFems78%3D (Pubitemid 28523116)
70. KJ Williams EA Fisher 2005 Oxidation, lipoproteins, and atherosclerosis: which is wrong, the antioxidants or the theory? Curr Opin Clin Nutr Metab Care 8 139 146 15716791 10.1097/00075197-200503000-00006 1:CAS:528: DC%2BD2MXivFSgs7o%3D
71. M Garelnabi D Litvinov S Parthasarathy 2010 Evaluation of a gas chromatography method for azelaic acid determination in selected biological samples N Am J Med Sci. 2 397 402 10.4297/najms.2010.2397
72. G Jürgens J Lang H Esterbauer 1986 Modification of human low-density lipoprotein by the lipid peroxidation product 4-hydroxynonenal Biochim Biophys Acta 875 103 114 3510062 (Pubitemid 16154787)
73. W Jessup G Jurgens J Lang H Esterbauer RT Dean 1986 Interaction of 4-hydroxynonenal-modified low-density lipoproteins with the fibroblast apolipoprotein B/E receptor Biochem J 234 245 248 3010955 1:CAS:528: DyaL28Xos1eitQ%3D%3D (Pubitemid 16053685)
74. H Esterbauer E Koller RG Slee JF Koster 1986 Possible involvement of the lipid-peroxidation product 4-hydroxynonenal in the formation of fluorescent chromolipids Biochem J 239 405 409 3814081 1:CAS:528:DyaL28Xls1OgsLw%3D (Pubitemid 16008460)
75. O Quehenberger E Koller G Jürgens H Esterbauer 1987 Investigation of lipid peroxidation in human low density lipoprotein Free Radic Res Commun 3 233 242 3508434 10.3109/10715768709069788 1:CAS:528:DyaL2sXkslGntrg%3D
76. HF Hoff TE Whitaker J O'Neil 1992 Oxidation of low density lipoprotein leads to particle aggregation and altered macrophage recognition J Biol Chem 267 602 609 1730620 1:CAS:528:DyaK38XjvFGrtQ%3D%3D
77. DV Nadkarni LM Sayre 1995 Structural definition of early lysine and histidine adduction chemistry of 4-hydroxynonenal Chem Res Toxicol 8 284 291 7766813 10.1021/tx00044a014 1:CAS:528:DyaK2MXjvVSku7o%3D
78. L Tsai PA Szweda O Vinogradova LI Szweda 1998 Structural characterization and immunochemical detection of a fluorophore derived from 4-hydroxy-2-nonenal and lysine Proc Natl Acad Sci U S A 95 7975 7980 9653125 10.1073/pnas.95.14.7975 1:CAS:528:DyaK1cXks1Slsr0%3D (Pubitemid 28326051)
79. G Xu Y Liu LM Sayre 2000 Polyclonal antibodies to a fluorescent 4-hydroxy-2-nonenal (HNE)-derived lysine-lysine cross-link: characterization and application to HNE-treated protein and in vitro oxidized low-density lipoprotein Chem Res Toxicol 13 406 413 10813658 10.1021/tx990200s 1:CAS:528:DC%2BD3cXisVOrtr0%3D (Pubitemid 30327161)
80. UM Marinari M Nitti MA Pronzato C Domenicotti 2003 Role of PKC-dependent pathways in HNEinduced cell protein transport and secretion Mol Aspect Med 24 205 211 10.1016/S0098-2997(03)00015-3 1:CAS:528:DC%2BD3sXlvVClsLo%3D (Pubitemid 36945020)
81. Y Awasthi R Sharma J Cheng Y Yang A Sharma SS Singhal S Awasthi 2003 Role of 4- hydroxynonenal in stress-mediated apoptosis signaling Mol Aspect Med 24 219 230 10.1016/S0098-2997(03)00017-7 1:CAS:528:DC%2BD3sXlvVClsLg%3D (Pubitemid 36945022)
82. Y Yang R Sharma A Sharma S Awasthi Y Awasthi 2003 Lipid peroxidation and cell cycle signaling: 4-hydroxynonenal, a key molecule in stress mediated signaling Acta Biochim Pol 50 319 336 12833161 1:CAS:528:DC%2BD3sXlvVChtrc%3D (Pubitemid 37034689)
83. D Litvinov K Selvarajan M Garelnabi L Brophy S Parthasarathy 2010 Anti-atherosclerotic actions of azelaic acid, an end product of linoleic acid peroxidation, in mice Atherosclerosis 209 449 454 19880116 10.1016/j. atherosclerosis.2009.09.076 1:CAS:528:DC%2BC3cXjvF2ku7s%3D